OxStem Limited | 553 followers on LinkedIn | Regeneration from within | OxStem is developing small molecule therapeutics targeting innate regeneration and repair.
| Website | http://www.oxstem.com |
| Revenue | $7.7 million |
| Employees | 9 (4 on RocketReach) |
| Founded | 2013 |
| Address | 23 Park End St, Oxford, Oxfordshire OX1 1HU, GB |
| Phone | +44 1865 275695 |
| Industry | Biotechnology, Research, Manufacturing General, Drug Discovery, Manufacturing, Healthcare, Medicinal Chemistry |
| Web Rank | 24 Million |
| Keywords | Regenerative Medicine, Small Molecule Therapeutics, Medical Research, Tissue Repair, Drug Discovery, Biotechnology, Pharmaceutical, Therapeutics, Molecular Medicine, Cell Therapy, Stem Cell Therapy, Wound Healing, Clinical Trials, Preclinical Development, Drug Development, Life Sciences, Biopharma, Health Tech |
| Competitors | Roche, Pfizer, AstraZeneca, Novartis, Biogen, Regeneron, GSK, CureVac, Moderna Therapeutics, Viva Biotech Ltd +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular OxStem Limited employee's phone or email?
OxStem Limited Questions
The OxStem Limited annual revenue was $7.7 million in 2026.
Michael Stein is the Chairman and CEO of OxStem Limited.
4 people are employed at OxStem Limited.
OxStem Limited is based in Oxford, Oxfordshire.
The NAICS codes for OxStem Limited are [325, 3254, 32541, 32].
The SIC codes for OxStem Limited are [283, 28].
Top OxStem Limited Employees
-
21
-
Michael Stein
CEO at OxStem Limited
United Kingdom1
Related Companies
